Lista de obras -

(CA)n microsatellite polymorphism of ERBB-1 in breast cancer.

artículo científico publicado en 2006

Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients

scientific article published on 16 April 2018

Are bilateral breast cancers different from breast cancers coexisting with ovarian cancer? An immunohistochemical analysis aimed at intrinsic tumor phenotype

artículo científico publicado en 2013

CD73 expression as a potential marker of good prognosis in breast carcinoma

artículo científico publicado en 2012

CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.

artículo científico publicado en 2015

Clinical and Biological Significance of Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients

article

Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples.

artículo científico

Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation

artículo científico publicado en 2014

Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer.

artículo científico publicado en 2012

Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized p

artículo científico publicado en 2005

Gene copy numbers of HER family in breast cancer

scientific article published on 28 July 2007

Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial

artículo científico publicado en 2005

Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study

artículo científico publicado en 2004

Heterogeneity of mesenchymal markers expression-molecular profiles of cancer cells disseminated by lymphatic and hematogenous routes in breast cancer

artículo científico publicado en 2013

Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.

artículo científico publicado en 2014

Modified direct-double-differential PCR for gene dosage quantification of HER2.

artículo científico publicado en 2005

Pattern of care in locally advanced breast cancer: focus on local therapy

artículo científico publicado en 2010

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group

artículo científico publicado en 2006

Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C192, UGT2B152 polymorphisms in breast cancer patients

artículo científico publicado en 2013

Prognostic significance of TOP2A gene dosage in HER-2-negative breast cancer

artículo científico publicado en 2012

Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.

artículo científico publicado en 2012

Radiotherapy for breast cancer in patients undergoing breast reconstruction or augmentation

artículo científico publicado en 2004

Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients

artículo científico publicado en 2019

Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.

artículo científico publicado en 2015

The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors

artículo científico publicado en 2003

Lista de obras de

(CA)n microsatellite polymorphism of ERBB-1 in breast cancer.

Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients

Are bilateral breast cancers different from breast cancers coexisting with ovarian cancer? An immunohistochemical analysis aimed at intrinsic tumor phenotype

CD73 expression as a potential marker of good prognosis in breast carcinoma

CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.

Clinical and Biological Significance of Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients

Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples.

Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation

Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer.

Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized p

Gene copy numbers of HER family in breast cancer

Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial

Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study

Heterogeneity of mesenchymal markers expression-molecular profiles of cancer cells disseminated by lymphatic and hematogenous routes in breast cancer

Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.

Modified direct-double-differential PCR for gene dosage quantification of HER2.

Pattern of care in locally advanced breast cancer: focus on local therapy

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group

Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients

Prognostic significance of TOP2A gene dosage in HER-2-negative breast cancer

Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.

Radiotherapy for breast cancer in patients undergoing breast reconstruction or augmentation

Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients

Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.

The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors

Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C192, UGT2B152 polymorphisms in breast cancer patients